| 3rd Jan 2023 1:15 pm |
RNS |
Interim Results - availability |
| 30th Dec 2022 7:00 am |
RNS |
Interim Results for the Six Months Ending 30Sept22 |
| 22nd Dec 2022 7:00 am |
RNS |
U.S. FDA Clearance of IND Application for OK-101 |
| 21st Dec 2022 7:00 am |
RNS |
OKYO to Participate at Biotech Showcase |
| 6th Dec 2022 7:00 am |
RNS |
OKYO files a registration statement with the SEC |
| 1st Dec 2022 7:00 am |
RNS |
Change of Auditor |
| 24th Nov 2022 7:00 am |
RNS |
Director/PDMR Shareholding |
| 21st Nov 2022 7:00 am |
RNS |
U.S. IND Filing on OK-101 for the Treatment of DED |
| 20th Oct 2022 7:00 am |
RNS |
OKYO to participate at 2022 ThinkEquity Conference |
| 8th Sep 2022 2:30 pm |
RNS |
OKYO interview on Bloomberg: RedChip Money Report |
| 7th Sep 2022 1:30 pm |
RNS |
Result of AGM |
| 30th Aug 2022 7:00 am |
RNS |
Q4 '22 IND planned followed by P2 with AmbioPharm |
| 19th Aug 2022 7:00 am |
RNS |
Notice of AGM |
| 18th Aug 2022 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 18th Aug 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 16th Aug 2022 7:00 am |
RNS |
Annual Financial Report |
| 9th Jun 2022 7:08 am |
RNS |
Director/PDMR Shareholding |
| 20th May 2022 7:00 am |
RNS |
Director/PDMR Shareholding |
| 19th May 2022 4:01 pm |
RNS |
Closing of Offering |
| 18th May 2022 10:10 am |
RNS |
Director/PDMR Shareholding |
| 17th May 2022 7:00 am |
RNS |
OKYO Announces Pricing of IPO of ADSs in the U.S. |
| 27th Apr 2022 7:00 am |
RNS |
Upcoming Presentations at Ophthalmic Conference |
| 7th Mar 2022 7:00 am |
RNS |
Additional Listing |
| 23rd Feb 2022 7:00 am |
RNS |
Patent issued: to treat ocular neuropathic pain |
| 21st Feb 2022 5:00 pm |
RNS |
CLN Conversion, exercise of Warrants, equity issue |
| 15th Feb 2022 7:00 am |
RNS |
Successful Pre-IND Meeting with the FDA on OK-101 |
| 1st Feb 2022 7:00 am |
RNS |
Director/PDMR Shareholding |
| 27th Jan 2022 7:00 am |
RNS |
Director/PDMR Shareholding |
| 26th Jan 2022 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 26th Jan 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 26th Jan 2022 7:00 am |
RNS |
Half-year Report |
| 14th Dec 2021 7:00 am |
RNS |
U.S. Patent issued for use of OK-101 to treat DED |
| 13th Dec 2021 7:00 am |
RNS |
OK-101:Anti-inflammatory & Pain-Reducing Potential |
| 6th Dec 2021 7:00 am |
RNS |
IND filing Q3 2022 and Phase 2 initiation Q4 2022 |
| 1st Dec 2021 7:00 am |
RNS |
Directorate Change |
| 19th Oct 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 19th Oct 2021 4:35 pm |
RNS |
Price Monitoring Extension |
| 19th Oct 2021 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 19th Oct 2021 2:00 pm |
RNS |
Price Monitoring Extension |
| 27th Sep 2021 12:06 pm |
RNS |
Result of AGM |
